FindMyKOL

Judson Hunt, MD

Basic profile

Medical City Dallas Hospital

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionDallas, TX · South CentralSpecialtyNephrologyFocusNephrology
Last active 2024FindMyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Judson Hunt is a Nephrology physician affiliated with Medical City Dallas Hospital. OpenAlex indexes 23 publications with 754 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
23publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

754citations

Citations across these publications.

13h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Boehringer Ingelheim Pharmaceuticals, Inc.
    Program year20222 payments
    $40
  • AstraZeneca Pharmaceuticals LP
    Program year20222 payments
    $31
  • ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
    Program year20221 payment
    $21
All 10 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    40.8%
    Statin15.2%
    Atorvastatin Calcium57%Rosuvastatin Calcium22%Pravastatin Sodium10%Simvastatin10%
    Part D≥53 patients
    Angiotensin receptor blocker (ARB)5.7%
    Losartan Potassium100%
    Part D≥29 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    17.5%
    Proton pump inhibitor7.3%
    Pantoprazole Sodium39%Omeprazole31%Esomeprazole Magnesium21%Aciphex9%
    Part D<11 patients
    H2 blocker3.8%
    Famotidine100%
    Part D≥23 patients

    + 3 more classes in this area

  • Anti-infectives

    15.9%
    Short-acting sulfonamides15.9%
    Sulfamethoxazole-Trimethoprim100%
    Part D≥80 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”